opdivo

What is Opdivo?

Opdivo (nivolumab) is a type of immunotherapy known as a checkpoint inhibitor. It works by blocking a protein called PD-1, which is found on the surface of T-cells. By inhibiting PD-1, Opdivo helps activate the immune system to attack cancer cells.

Frequently asked queries:

What is Opdivo?
How is Opdivo used in Gynecology?
What are the benefits of Opdivo in Gynecologic Oncology?
What are the side effects of Opdivo?
Who is a candidate for Opdivo?
How is Opdivo administered?
What is the future of Opdivo in Gynecologic Oncology?
How Does Scarring Affect Reproductive Health?
What is the Role of Referrals?
What Types of Email Alerts are Common in Gynecology?
Why Do Pregnant Women Experience Leg Cramps?
How Can Technology Aid in Effective Gynecological Care?
How Accurate is Gestational Age Estimation?
What are Pelvic Injuries?
What are Molar Pregnancies?
How Are Treatment Options Evaluated?
What is Continuous Monitoring in Gynecology?
How to Care for Yourself Postnatally?
What are some common maternal complications during pregnancy?
What Resources Does the NOF Offer?
Follow Us
Top Searches
Cystic Ovarian Disease Ectopic Pregnancy Endometriosis Menorrhagia Ultrasound

Partnered Content Networks

Relevant Topics